Table 1.
Scenario | Brief Description | Comments |
---|---|---|
Baseline | Demographic changes only | Constant rate of LTBI reactivation beyond five years after infection, no change in TB dynamics in 1980s – 1990s |
Declining Progression | Allows declining rate of LTBI reactivation | As in Baseline, but allows for linear decline in the rate of LTBI reactivation with time since infection |
1980s Increase | Increased TB incidence from 1984 to 1992 | As in Declining Progression, but allows for higher rates of transmission and reactivation as observed from 1984 to 1992, without specifying a specific mechanism (e.g., HIV or worsening TB control infrastructure) |
Differential Progression | Different reactivation rates in US-born versus foreign-born | As in 1980s Increase, but allows for different rates of progression from LTBI to active TB in US-born and foreign born individuals, as well as allowing the rate of progression in foreign-born individuals with LTBI to decline by 1·5 to 5·25% per year after 2007, without specifying a specific mechanism (e.g., due to improved nutritional/immune status).* |
Reduced Importation | Reduced importation of subclinical TB from 2007 to 2012 | As in the 1980s Increase scenario, but models a decrease in imported subclinical TB without specifying a specific mechanism (e.g. changing patterns of immigration or use of TB culture rather than sputum smear microscopy to screen some foreign-born persons seeking permanent residence in the US prior to entry17). We represent this decrease as a linear reduction in the risk of incident active TB among immigrants in their first year after arrival; we assume that in 2007 immigrants have a normal risk, but by 2012 (and after) have that first-year risk cut in half. |
Rates of decline were selected based on preliminary simulations. Our primary analysis of this scenario assumed that LTBI progression rates among the foreign-born continued to decline through 2025. As it is not clear that such a decline would continue year after year, we conducted a secondary analysis which assumed LTBI progression rates did not decline further after 2015. Further details are provided in the Supplement.